PDS Biotechnology Corp
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
PDSB$1.23+5.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
EXHIBIT INDEX
| Exhibit Number | Exhibit Description |
| 1.1 | Sales Agreement, dated June 15, 2026, by and among PDS Biotechnology Corporation, Yorkville Securities, LLC and B. Riley Securities, Inc. (filed as Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on June 15, 2026, and incorporated by reference herein |
| 4.1 | Form of Promissory Note (YA II PN, Ltd.) (filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and incorporated by reference herein) |
| 4.2 | Form of Warrant (YA II PN, Ltd.) filed as Exhibit 4.2 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and incorporated by reference herein) |
| 10.1 | Securities Purchase Agreement by and between PDS Biotechnology Corporation and YA II PN, Ltd., dated as of April 30, 2026 (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 15, 2026, and incorporated by reference herein) |
| 10.2 | Form of Registration Rights Agreement (YA II PN, Ltd.) (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and incorporated by reference herein) |
| 10.3 | Form of Guaranty Agreement (YA II PN, Ltd.) (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and incorporated by reference herein) |
| 31.1* | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
| 101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents. |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101. |
| * | Filed herewith (unless otherwise noted as being furnished herewith) |
|---|
| + | Pursuant to Item 601(a)(5) of Regulation S-K, schedules have been omitted and will be furnished on a supplemental basis to the Securities and Exchange Commission upon request. |
|---|
Index
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.